- Home
- ACN vs ABT Comparison
ACN vs ABT Comparison
Compare ACN & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACN
- ABT
- Stock Information
- Founded
- ACN 1989
- ABT 1888
- Country
- ACN Ireland
- ABT United States
- Employees
- ACN N/A
- ABT N/A
- Industry
- ACN Business Services
- ABT Medical/Dental Instruments
- Sector
- ACN Consumer Discretionary
- ABT Health Care
- Exchange
- ACN Nasdaq
- ABT Nasdaq
- Market Cap
- ACN 161.9B
- ABT 233.7B
- IPO Year
- ACN N/A
- ABT N/A
- Fundamental
- Price
- ACN $237.84
- ABT $131.42
- Analyst Decision
- ACN Buy
- ABT Strong Buy
- Analyst Count
- ACN 22
- ABT 19
- Target Price
- ACN $338.45
- ABT $143.68
- AVG Volume (30 Days)
- ACN 3.8M
- ABT 4.8M
- Earning Date
- ACN 09-25-2025
- ABT 10-15-2025
- Dividend Yield
- ACN 2.49%
- ABT 1.80%
- EPS Growth
- ACN 15.02
- ABT 151.50
- EPS
- ACN 12.56
- ABT 7.97
- Revenue
- ACN $68,482,535,999.00
- ABT $43,109,000,000.00
- Revenue This Year
- ACN $8.05
- ABT $7.60
- Revenue Next Year
- ACN $5.41
- ABT $7.84
- P/E Ratio
- ACN $18.92
- ABT $16.48
- Revenue Growth
- ACN 6.21
- ABT 5.85
- 52 Week Low
- ACN $236.08
- ABT $110.86
- 52 Week High
- ACN $398.35
- ABT $141.23
- Technical
- Relative Strength Index (RSI)
- ACN 30.39
- ABT 49.56
- Support Level
- ACN $240.66
- ABT $127.45
- Resistance Level
- ACN $245.25
- ABT $134.96
- Average True Range (ATR)
- ACN 5.84
- ABT 2.25
- MACD
- ACN -0.96
- ABT -0.05
- Stochastic Oscillator
- ACN 7.84
- ABT 52.86
About ACN Accenture plc (Ireland)
Accenture is a leading IT services firm that provides consulting, system integration, and business process outsourcing to enterprises around the world. Customers of Accenture come from a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture is the world's largest professional services company by headcount with around 800,000 employees in over 120 countries.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.